.jpg)
STAT+: Medicare reverses course on plan to hide hospital safety data next year
Medicare will continue to report hospital safety data as usual next year after the program,…
Category: Biotech
Opinion: Paxlovid rebound happens, though why and to whom are still a mystery
As an emergency department physician in New York, I often field calls about medical issues…
STAT+: How much are patients actually using mental health apps? Research on engagement is elusive
As companies selling health care apps struggle to prove to a skeptical system that they…
STAT+: Pharmalittle: West Virginia cities reach deal with wholesalers over opioid crisis; Democrats’ economic plan would raises taxes on pharma
Top of the morning to you. And a fine one it is. Lots of sunshine…
A chaotic sprint to lower insulin prices and AIDS activists go after Biden on monkeypox
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Alexis Borisy, biotech’s ‘man of many hats,’ dons another
Alexis Borisy is the first person to admit he has a lot of projects going…
Opinion: STAT+: Hospitals, health systems play critical roles in the real-world data movement
Since the start of the pandemic, the health care and life sciences sectors have relied…
Cities are lobbying to host the ARPA-H headquarters. Experts don’t understand why
WASHINGTON — America’s mayors are drooling over President Biden’s new high-stakes research agency, ARPA-H. They…
STAT+: Hospitals win higher payments from Medicare after lobbying campaign
Hospitals secured significantly larger payments from Medicare for 2023, after months of lobbying centered around…
Synthetic mouse embryos created from stem cells — without sperm, eggs, or a uterus
Lit from below by the microscope’s soft glow, the translucent mouse embryos looked exactly as…
STAT+: Major European research funders often fail to set policies or monitor progress on clinical trial transparency
Nearly two dozen major organizations that fund medical research in Europe often failed to set…
Wall Street’s love affair with insurers, hospitals pressure Medicare, and swimming in a risk pool
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
Opinion: Keeping climate provisions in the budget reconciliation act is a key step toward protecting Americans’ health
Last week’s surprise agreement between Sen. Joe Manchin (D-W.Va.) and Senate Majority Leader Chuck Schumer…
STAT+: Pharmalittle: Global demand for monkeypox vaccine will be hard to meet; Amgen dispute with IRS heats up
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
With the help of a sticky, stretchy material, scientists design a continuous ultrasound system
It took hundreds of failed experiments, sticking gummy gels to all sorts of surfaces, for…
Opinion: Fast science can be good science, even more so when lives are at stake
Drug development has been conducted at the same slow and incremental pace for so long…
Opinion: Americans deserve better than ‘destination hallway’ in emergency departments and hospital wards
As the literal and figurative front door to many hospitals, the emergency department can offer…
The campaign to rename monkeypox gets complicated
Since the earliest days of the current global monkeypox outbreak, scientists and public health authorities…
From low pay to workplace culture, obstacles litter the path to diversity in EMS
A single mother, Tashina Hosey quit her job at a Pittsburgh post office when she…
Opinion: WTO: Don’t make a bad situation worse by granting intellectual property waivers for Covid-19 therapeutics and diagnostics
The World Trade Organization recently agreed to suspend patent protections for Covid-19 vaccines. The trade…
Biden tests positive for Covid-19 again — in a case of ‘Paxlovid rebound’
President Biden tested positive for the coronavirus again Saturday, the White House said, an example…
U.S. polio case tied to viruses detected in U.K., Israel, suggesting silent spread
Genetic analysis of the virus responsible for the first case of polio in the United…
STAT+: This billionaire has quietly driven Boston’s biotech industry for decades
Among the small bunch of billionaires that the local biotech industry has created, Tim Springer…
STAT+: Sarepta to seek early FDA approval for gene therapy to treat Duchenne muscular dystrophy
Sarepta Therapeutics said Friday that it intends seek regulators’ approval for its gene therapy to…
STAT+: Pharmalittle: Pharma wages ‘hail Mary’ campaign to sink reconciliation bill; Moderna inks $1.74 billion deal with U.S. for Omicron shot
And so, another working week will soon draw to a close. Not a moment too…
Opinion: A better understanding of human diversity is needed to equitably advance precision medicine
Precision medicine — tailoring a treatment to an individual’s disease — requires understanding the individual’s…
Drug companies could create new drugs to protect the Covid vulnerable. Why aren’t they?
Twice, Janet Handal thought she would get a reprieve from semi-lockdown life. The first was…
STAT+: A ViiV deal to license its HIV prevention shot to poor countries runs into criticism
In a much ballyhooed move, ViiV Healthcare finalized a deal to license its long-acting injectable…
STAT+: Teladoc’s earnings point to potential threats to the telehealth industry
Telehealth giant Teladoc is bracing for disappointing earnings this year as it faces headwinds that…
Listen: Helen Branswell on monkeypox, plus: an FDA controversy and fake Alzheimer’s data
Can monkeypox be contained? Are snortable Covid-19 vaccines on the way? And when is a…
Inside a secretive deal between IQVIA and Experian, Teladoc’s latest hit, & APA weighs in on virtual ADHD care
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
The view on drug pricing from Wall Street, a pharma-friendly Dem holds firm, and what’s next for a big telehealth bill
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Pharmalittle: AbbVie’s Allergan reaches $2 billion deal on opioid lawsuits; internal IQVIA documents question patient data privacy
Rise and shine, folks. Another busy day is upon us. And it looks to be…
Opinion: I learned up close and personal about the necessity of improving diversity in clinical trials
As the biopharmaceutical industry places increased emphasis on improving the diversity of participants in clinical…
STAT+: Top IQVIA lawyer declines to discuss Experian relationship, but pledges Americans’ medical secrets are safe
For years, the health data company IQVIA has quietly purchased detailed financial and demographic information…
Opinion: STAT+: How to close biopharma’s data science and engineering skills gap
In biopharma research and development, laboratory data now exist in petabytes. Today’s fastest liquid-handling robots…
Researchers revive abandoned technique in effort to make artificial human eggs in a test tube
In a little-noticed study published earlier this year, scientists from Oregon Health & Science University…
STAT+: Internal documents on IQVIA’s secretive relationship with Experian undercut its image as a Fort Knox of patient data
To the outside world and its countless health care customers, the data powerhouse IQVIA has…
.jpg)
Buprenorphine treatment for veterans with opioid use disorder increased as care shifted to telehealth during Covid, study finds
Drug treatment of veterans with opioid use disorder increased during the first year of the…
Daily Vitamin D supplements don’t lower risk of bone fractures, study finds
Whether created from sunlight or taken in by food, vitamin D assists in the mineralizing…
Bacterium that causes rare but dangerous disease likely endemic along Gulf Coast, CDC says
Disease detectives investigating a pair of medical mysteries in Mississippi have come to an unwelcome…
STAT+: AbbVie is scolded by a trade group over sales rep ‘strategically loitering’ in a hospital
In an embarrassing episode for AbbVie, the company was reprimanded by a U.K. pharmaceutical industry…
WHO recommends men who have sex with men reduce sex partners to limit monkeypox risk
Men who have sex with men should consider reducing the number of sexual partners they…
STAT+: Wyden says Merck and Abbott aren’t cooperating with probe into pharma tax practices
In his ongoing quest to probe pharmaceutical industry tax practices, the head of the U.S….
Can we really get better Covid vaccines? There are big hurdles, but some hope
On Tuesday, White House officials gathered scientists, pharmaceutical executives, and experts in public health at…
STAT+: Pharmalittle: Teva reaches $4.25 billion deal over its role in opioid crisis; feds probe Cassava over Alzheimer’s drug data
Top of the morning to you. Another deliciously shiny day is unfolding over the Pharmalot…
Opinion: The future of health care is here. When will it be everywhere?
To paraphrase Canadian-American speculative fiction writer William Gibson: The future of health care is already…
STAT+: Genomics is racing toward a $100 genome. Are we ready for it?
As the cost of DNA sequencing plummets, we’re fast approaching a point when decoding a…
Opinion: The Morris ALS Principles: A model for empowering all disease communities
The FDA’s decision to delay its highly anticipated review of AMX0035, a new drug for…
Drawing on therapy developed to save soldiers, an app aims to prevent suicide in those at highest risk
It’s a problem so complex, so fraught with stigma and treatment complications, that innovation has…